Covid-19 Currency Expansion Healthcare Investment Renminbi Yuan
Jiuan Medical has attracted significant attention in the capital market in 2026. The company’s stock price has soared from 40 yuan per share to a high of 94.94 yuan per share, currently hovering around 75 yuan per share. Over the years, Jiuan Medical has experienced significant fluctuations in its development. Leveraging its COVID-19 antigen testing business, the company achieved remarkable performance and stock price growth. However, with the normalization of epidemic prevention and control, the demand for COVID-19 testing plummeted in 2023, leading to pressure on both stock price and performance.
News Timeline:
Track the development of this news story across the Internet.